Randomized Controlled Trial of Rituximab and Cost‐Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome

Bowman, Simon; Everett, Colin; O’Dwyer, John; Emery, Paul; Pitzalis, Costantino; Ng, Wan‐Fai; Pease, Colin; Price, Elizabeth; Sutcliffe, Nurhan; Gendi, Nagui; Hall, Frances; Ruddock, Sharon; Fernandez, Catherine; Reynolds, Catherine; Hulme, Claire; Davies, Kevin; J Edwards, Christopher; Lanyon, Peter; J. Moots, Robert; Roussou, Euthalia; Giles, Ian; Sharples, Linda; Bombardieri, Michele

doi:10.1002/art.40093

Public

Randomized Controlled Trial of Rituximab and Cost‐Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome

Published in Arthritis & Rheumatology • Mar 10, 2017

Authors:

Simon Bowman

Colin Everett

John O’Dwyer

Abstract

OBJECTIVE: To investigate whether rituximab, an anti-B cell therapy, improves symptoms of fatigue and oral dryness in patients with primary Sjögren's syndrome (SS). METHODS: We conducted a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial that included health economic a...

View

Open Access

Subject

Medicine

Rituximab

Placebo

Generate AI Take for this paper

Highlights, strengths & weaknesses, commercial applications, and societal impact — written for this paper on demand.

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!